Clene Inc. Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CLNNW and buy or sell other stocks, ETFs, and their options commission-free!About CLNNW
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs.
CEORobert Dee Etherington, MBA
CEORobert Dee Etherington, MBA
Employees—
Employees—
HeadquartersSalt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded2013
Founded2013
Employees—
Employees—
CLNNW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume26.26K
Average volume26.26K
High today$0.006
High today$0.006
Low today$0.006
Low today$0.006
Open price$0.006
Open price$0.006
Volume100.00
Volume100.00
52 Week high$0.0513
52 Week high$0.0513
52 Week low$0.004
52 Week low$0.004
Stock Snapshot
The current Clene Inc. Warrant(CLNNW) stock price is $0.01.
During the trading session on 2025-12-17, Clene Inc. Warrant(CLNNW) shares reached a daily high of $0.01 and a low of $0.01. At a current price of $0.01, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading volume for Clene Inc. Warrant(CLNNW) stock has reached 100, versus its average volume of 26.26K.
Over the past 52 weeks, Clene Inc. Warrant(CLNNW) stock has traded between a high of $0.05 and a low of $0.00.
Over the past 52 weeks, Clene Inc. Warrant(CLNNW) stock has traded between a high of $0.05 and a low of $0.00.